Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant GTX and Chemoradiation for Locally Advanced Pancreatic Cancer
NCT01065870Phase 3Unknown
- Sponsor
- Columbia University
- Start
- Dec 2009
- Primary completion
- Dec 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, docetaxel, capecitabine in pancreatic adenocarcinoma (PDAC), sponsored by Columbia University. Status: unknown.
02
Drugs
gemcitabinedocetaxelcapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01065870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065870.